The reported statements, read against the company's own industry.
Financials view
Market Capitalization
19.51BTRY
388.52M · vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
11.63x
vs Gold peers
Updated Oct 26, 2026
Revenue (TTM)
17.73BTRY
353.03M · vs all stocks (USD)
Updated Oct 26, 2026
Profit Margin
10.18%
vs Gold peers
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives 3.98%.Updated Oct 26, 2026
Beta
0.5860x
vs all stocks
Updated Oct 26, 2026
52-Week Change
6.90%
vs all stocks
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Market Capitalization
19.51BTRY
388.52M · vs all stocks (USD)
Updated Oct 26, 2026
Enterprise Value
13.26BTRY
263.99M · vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
11.63x
vs Gold peers
Updated Oct 26, 2026
PEG Ratio
-0.0124x
vs Gold peers
Updated Oct 26, 2026
Price to Sales (TTM)
0.8883x
vs Gold peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.1×.Updated Oct 26, 2026
Price to Book (MRQ)
1.23x
vs Gold peers
Updated Oct 26, 2026
Enterprise to Revenue
1.78x
vs Gold peers
Provider-reported. Enterprise Value ÷ Revenue (TTM) on this page gives 0.75×.Updated Oct 26, 2026
Enterprise to EBITDA
4.65x
vs Gold peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 1.83×.Updated Oct 26, 2026
Gross Margin
62.76%
vs Gold peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 41.14%.Updated Oct 26, 2026
Profit Margin
10.18%
vs Gold peers
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives 3.98%.Updated Oct 26, 2026
Operating Margin
20.36%
vs Gold peers
Updated Oct 26, 2026
Return on Assets (TTM)
8.29%
vs Gold peers
Updated Oct 26, 2026
Return on Equity (TTM)
9.43%
vs Gold peers
Updated Oct 26, 2026
Revenue (TTM)
17.73BTRY
353.03M · vs all stocks (USD)
Updated Oct 26, 2026
Revenue per Share (TTM)
84.58TRYUpdated Oct 26, 2026
Quarterly Revenue Growth
19.30%
vs Gold peers
Updated Oct 26, 2026
Gross Profit (TTM)
7.29BTRY
145.25M · vs all stocks (USD)
Updated Oct 26, 2026
EBITDA (TTM)
7.24BTRY
144.10M · vs all stocks (USD)
Updated Oct 26, 2026
Net Income (TTM)
705.70MTRY
14.05M · vs all stocks (USD)
Updated Oct 26, 2026
Quarterly Earnings Growth (YoY)
57.65%
vs Gold peers
Updated Oct 26, 2026
Operating Cash Flow (TTM)
8.27BTRY
164.69M · vs all stocks (USD)
Updated Oct 26, 2026
Levered Free Cash Flow (TTM)
705.70MTRY
14.05M · vs all stocks (USD)
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Trailing Annual Dividend Rate
0.00TRYUpdated Oct 26, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Payout Ratio
0.00%
vs Gold peers
Updated Oct 26, 2026
Minority Interest (Equity)
33.00BTRYFY2025 · Dec 31, 2025
Revenue
17.73BTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
10.43BTRYFY2025 · Dec 31, 2025
Gross Profit
7.29BTRYFY2025 · Dec 31, 2025
Operating Income
3.48BTRY
69.28M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
5.79BTRYFY2025 · Dec 31, 2025
Income Tax Expense
2.19BTRYFY2025 · Dec 31, 2025
Net Income
3.59BTRYFY2025 · Dec 31, 2025
EBIT
5.82BTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
3.62BTRYFY2025 · Dec 31, 2025
Research & Development
1.53BTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
1.96BTRYFY2025 · Dec 31, 2025
Other Operating Expenses
544.82MTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.97BTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
32.38MTRYFY2025 · Dec 31, 2025
EPS (Basic)
2.72TRYFY2025 · Dec 31, 2025
EPS (Diluted)
2.72TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
259.68MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
259.68MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
3.59BTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.89BTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
7.27BTRYFY2025 · Dec 31, 2025
Free Cash Flow
1.31BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
46.34BTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
3.59BTRYFY2025 · Dec 31, 2025
Other Non-cash Items
1.24BTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
927.99MTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
1.52BTRYFY2025 · Dec 31, 2025
Capital Expenditures
-5.97BTRYFY2025 · Dec 31, 2025
Net Intangibles (CF)
-12.72MTRYFY2025 · Dec 31, 2025
Net Acquisitions
0.00TRYFY2025 · Dec 31, 2025
Purchase of Investments
-1.01BTRYFY2025 · Dec 31, 2025
Sale of Investments
2.15BTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-4.82BTRYFY2025 · Dec 31, 2025
Long-term Debt Issuance
112.00MTRYFY2025 · Dec 31, 2025
Long-term Debt Payments
-20.00MTRYFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00TRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
92.00MTRYFY2025 · Dec 31, 2025
Shares Outstanding
259.79MSharesUpdated Oct 26, 2026
Float Shares
475.41KSharesUpdated Oct 26, 2026
% Held by Insiders
71.75%
vs all stocks
Updated Oct 26, 2026
% Held by Institutions
1.56%
vs all stocks
Updated Oct 26, 2026
Total Cash (MRQ)
75.39MTRY
1.50M · vs all stocks (USD)
Updated Oct 26, 2026
Total Cash per Share (MRQ)
81.16TRYUpdated Oct 26, 2026
Total Debt (MRQ)
116.98MTRY
2.33M · vs all stocks (USD)
Updated Oct 26, 2026
Total Debt to Equity (MRQ)
0.0021x
vs Gold peers
Updated Oct 26, 2026
Current Ratio (MRQ)
4.35x
vs Gold peers
Updated Oct 26, 2026
Book Value per Share (MRQ)
61.02TRYUpdated Oct 26, 2026
Total Assets
50.87BTRY
1.01B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
21.12BTRYFY2025 · Dec 31, 2025
Total Liabilities
5.50BTRYFY2025 · Dec 31, 2025
Total Non-current Assets
29.75BTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.15BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
4.34BTRYFY2025 · Dec 31, 2025
Cash
292.29MTRYFY2025 · Dec 31, 2025
Cash Equivalents
6.06BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
6.36BTRYFY2025 · Dec 31, 2025
Other Short-term Investments
11.19BTRYFY2025 · Dec 31, 2025
Accounts Receivable
57.73MTRYFY2025 · Dec 31, 2025
Inventory
3.03BTRYFY2025 · Dec 31, 2025
Accounts Payable
379.40MTRYFY2025 · Dec 31, 2025
Short-term Debt
102.07MTRYFY2025 · Dec 31, 2025
Other Current Liabilities
33.60MTRYFY2025 · Dec 31, 2025
Long-term Debt
1.31MTRYFY2025 · Dec 31, 2025
Common Stock (Book)
259.79MTRYFY2025 · Dec 31, 2025
Retained Earnings
5.67BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
45.38BTRY
903.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
69.35TRYUpdated Oct 26, 2026
52-Week High
122.80TRYUpdated Oct 26, 2026
52-Week Change
6.90%
vs all stocks
Updated Oct 26, 2026
Beta
0.5860x
vs all stocks
Updated Oct 26, 2026
50-Day MA
99.57TRYUpdated Oct 26, 2026
200-Day MA
98.01TRYUpdated Oct 26, 2026
Avg 10-Day Volume
1.03MSharesUpdated Oct 26, 2026
Avg 30-Day Volume
1.27MSharesUpdated Oct 26, 2026
Diluted EPS (TTM)
6.46TRYUpdated Oct 26, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.41: safe zoneNotable
Altman Z-Score: 3.41
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.